Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 11/2004

01-11-2004 | Letter to the Editor

Angioimmunoblastic T-cell lymphoma with renal involvement: a case report of direct bilateral kidney invasion by lymphoma cells

Authors: Akiko Goto, Akio Takada, Satoshi Yamamoto, Atsushi Notoya, Masaya Mukai

Published in: Annals of Hematology | Issue 11/2004

Login to get access

Excerpt

A few cases have been reported of renal failure associated with angioimmunoblastic T-cell lymphoma (AILT) [1, 2], but no case has been described showing direct invasion of the kidneys. To our knowledge, this is the first case report showing direct invasion of the kidneys by lymphoma cells in AILT. …
Literature
1.
Wood WG, Harkins MM (1979) Nephropathy in angioimmunoblastic lymphadenopathy. Am J Clin Pathol 71:58–63PubMed
2.
Duwaji MS, Shemin DG, Medeiros LJ, Esparza AR (1995) Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma. Arch Pathol Lab Med 119:377–380PubMed
3.
Straus DJ, Filippa DA, Lieberman PH, Koziner B, Tzvithaler H, Clarkson BD (1983) The non-Hodgkin’s lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer 49:2115–2135
4.
Richards MA, Mootoosamy I, Reznek RH, Webb JAW, Lister TA (1990) Renal involvement in patients with lymphoma: clinical and pathological features in 23 cases. Hematol Oncol 8:105–110PubMed
5.
Morel P, Dupriez B, Herbrecht R, Bastion Y, Tilly H, Delannoy A, Haioun C, Nouvel C, Bouabdallah K, Baumelou E, Gisselbrecht C (1994) Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Br J Cancer 70:154–159PubMed
Metadata
Title
Angioimmunoblastic T-cell lymphoma with renal involvement: a case report of direct bilateral kidney invasion by lymphoma cells
Authors
Akiko Goto
Akio Takada
Satoshi Yamamoto
Atsushi Notoya
Masaya Mukai
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 11/2004
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-004-0929-9

Other articles of this Issue 11/2004

Annals of Hematology 11/2004 Go to the issue

Original Article

Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome

Review Article

Beneficial and ominous aspects of the pleiotropic action of erythropoietin

Original Article

Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study

Letter to the Editor

Rhabdomyosarcoma of the perianal region presenting as acute leukemia

Original Article

Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia

Letter to the Editor

Is the antiplatelet effect of aspirin affected by systemic inflammation?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits